In adolescents and Older people, Szefler et al confirmed that the addition of FeNO measurement being an indicator of bronchial asthma Management resulted in higher doses of ICS and very long-acting ?2 agonists than did conventional guideline-primarily based treatment method, and didn't establish advancements in asthma indicators or lung function [o